Clinical trials
Glycogen Storage Disease Type II trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 2 |
| Astellas Gene Therapies | 1 |
| Genzyme, a Sanofi Company | 1 |
| MidAtlantic Retina | 1 |
| Spark Therapeutics, Inc. | 1 |
| University of California, Irvine | 1 |
| University of Florida | 1 |
| University of Missouri-Columbia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glycogen Storage Disease Type II | 9 |
| Lysosomal Storage Diseases | 2 |
| Amyotrophic Lateral Sclerosis | 1 |
| Charcot-Marie-Tooth Disease | 1 |
| Lambert-Eaton Myasthenic Syndrome | 1 |
| Macular Degeneration | 1 |
| Mitochondrial Myopathies | 1 |
| Motor Neuron Disease | 1 |
| Muscle Weakness | 1 |
| Muscular Atrophy, Spinal | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.